Esteban Martínez, MD, PhD

Esteban Martínez was born in León, Spain, in 1963. He studied at the School of Medicine of Valladolid, Spain, from 1980 to 1986. He specialized in Internal Medicine at Hospital de la Santa Creu i Sant Pau in Barcelona, Spain, from 1988 to 1992, and, in 1996, achieved his PhD from the Autonomous University of Barcelona with studies on neurosurgical infections. Esteban Martínez started working at Hospital Clínic in Barcelona and he currently holds the position of Senior Consultant in Infectious Diseases. Since 1996, he has devoted his time to clinical care and research of HIV-infected persons, and, from 2001, he has been teaching infectious diseases at the University of Barcelona as Associate Professor of Medicine. He is member of the Scientific Board of the International Workshop on Adverse Drug Reactions and Co-morbidities in HIV, has been co-author of the Spanish Guidelines on Antiretroviral Therapy from 2001, Spanish Guidelines for Metabolic Complications in HIV-infected patients since 2003, Spanish Guidelines for Kidney (2010) and Bone (2013) Complications in HIV-Infected patients, and Guidelines for the Prevention and Management of Non-Infectious Co-Morbidities in HIV (European AIDS Clinical Society) from 2007. He is a member of Grupo de Estudio de SIDA (GESIDA), Sociedad Española de Enfermedades Infeccioas y Microbiología Clínica (SEIMC), and European AIDS Clinical Society (EACS). He was elected as Regional (South Europe) Representative for EACS in 2012 for a 4-year period, and has been a founding member of the International Symposium on Psychiatry and HIV (http://www.psiquiatria-vih.com/). He is member of the Editorial Board of HIV Medicine, The Scientific World Journal and The Open AIDS Journal. His fields of interests span opportunistic infections, simplification of antiretroviral therapy, incidence and causes of death in HIV-infected persons receiving antiretroviral therapy, toxicity of antiretrovirals, lipodystrophy (incidence, diagnosis, risk, and interventions), and non-infectious complications in HIV-infected patients (central nervous system, kidney, bone, and particularly, cardiovascular diseases). He has authored more than 200 papers and has lead 9 doctoral thesis. He has served as a reviewer for Dirección General de Investigación Científica y Técnica (Spanish Goverment), Agence Nationale de Recherche sur le Sida, UK Medical Research Council, South African Medical Research Council, and University of New South Wales. He has also served regularly as reviewer for major journals on Medicine (New England Journal of Medicine, Lancet, JAMA, Annals of Internal Medicine, Medicina Clínica), Infectious Diseases (Clinical Infectious Diseases, Journal of Infectious Diseases, Emerging Infectious Diseases, Enfermedades Infecciosas y Microbiología Clínica), Chemotherapy (Journal of Antimicrobial Chemotherapy, Antiviral Therapy), and HIV/AIDS (AIDS, JAIDS, HIV Medicine, AIDS Research and Human Retroviruses).